Literature DB >> 23640183

Pharmacopolitics: reflections on a subspecialty of clinical pharmacology?

Michael D Rawlins1.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23640183     DOI： 10.1007/s00228-013-1473-0

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  7 in total

Review 1.  Early thrombolysis for the treatment of acute myocardial infarction: a systematic review and economic evaluation.

Authors:  A Boland; Y Dundar; A Bagust; A Haycox; R Hill; R Mujica Mota; T Walley; R Dickson
Journal:  Health Technol Assess       Date:  2003       Impact factor: 4.014

2.  National Institute for Clinical Excellence and its value judgments.

Authors:  Michael D Rawlins; Anthony J Culyer
Journal:  BMJ       Date:  2004-07-24

3.  Pharmacopolitics and deliberative democracy.

Authors:  Michael D Rawlins
Journal:  Clin Med (Lond)       Date:  2005 Sep-Oct       Impact factor: 2.659

4.  Setting health care priorities in Oregon. Cost-effectiveness meets the rule of rescue.

Authors:  D C Hadorn
Journal:  JAMA       Date:  1991-05-01       Impact factor: 56.272

5.  All trials must be registered and the results published.

Authors:  Iain Chalmers; Paul Glasziou; Fiona Godlee
Journal:  BMJ       Date:  2013-01-09

Review 6.  Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials.

Authors:  Robin Christensen; Pernelle Kruse Kristensen; Else Marie Bartels; Henning Bliddal; Arne Astrup
Journal:  Lancet       Date:  2007-11-17       Impact factor: 79.321

7.  Pharmacovigilance: paradise lost, regained or postponed? The William Withering Lecture 1994.

Authors:  M D Rawlins
Journal:  J R Coll Physicians Lond       Date:  1995 Jan-Feb
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.